Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
It's important to know when cash back credit cards incur taxes. Learn the key moments to prepare for potential tax impacts.
22,745 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Argan stock ascended today as investors cheered stronger profits and a brighter outlook for energy infrastructure tie...
Quadrant Private Wealth recently boosted its stake in Bluerock Private Real Estate Fund by about $13.6 million. This ...
Broadcom reports a surge in AI semiconductor revenue and points to a path beyond $100 billion in AI-chip sales by 202...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Rigetti Computing stock rocketing headlines a broader burst of investor interest in quantum tech. Here’s what’s drivi...
A surprising signal from Nvidia's CEO has AMD investors buzzing. This article breaks down what Jensen Huang's comment...
Two enormous EV players are positioned to leverage a multi-trillion AI opportunity. This article breaks down why thes...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
SpaceX IPO chatter has investors buzzing and critics worried. This piece breaks down why the hype could outpace reali...
A leading cloud giant reportedly inks a multi-year deal with a niche semiconductor maker. This article breaks down wh...
Charles Schwab stock bumping higher today caught investors' attention as May metrics showed record asset inflows. Thi...